levodopa has been researched along with pyrimidinones in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barczyńska, J; Felsztyńska, J; Kedzierska, L; Wilimowski, M; Witkowska, M; Wojewódzki, W | 1 |
Bianco, VV; Lafiandra, D; Lattanzio, V | 1 |
Arese, P; Sisini, A; Spanu, A | 1 |
Burbano, C; Cuadrado, C; Cubero, JI; Muzquiz, M | 1 |
Bagetta, V; Calabresi, P; Di Filippo, M; Fusco, FR; Ghiglieri, V; Giampà, C; Paillè, V; Pendolino, V; Picconi, B; Sgobio, C; Tozzi, A | 1 |
5 other study(ies) available for levodopa and pyrimidinones
Article | Year |
---|---|
Central action of new derivatives of tetrahydropirimidinedione-4,6.
Topics: Amphetamine; Analgesics; Animals; Brain; Chloral Hydrate; Drug Synergism; Female; Furans; Hexobarbital; Levodopa; Male; Mice; Movement; Pentylenetetrazole; Pyrimidinones; Reserpine; Seizures; Sleep | 1979 |
Hingh-performance reversed-phase liquid chromatography (HPLC) of favism-inducing factors in Vicia faba L.
Topics: Chromatography, High Pressure Liquid; Fabaceae; Favism; Glucosides; Glycosides; Levodopa; Plants, Medicinal; Pyrimidinones; Seeds; Uracil; Uridine | 1982 |
[Genetic improvement in Vicia faba and favism. I. Distribution and levels of presumably hemolytic metabolites].
Topics: Ascorbic Acid; Fabaceae; Favism; Glucosides; Hemolysin Proteins; Levodopa; Plants, Medicinal; Pyrimidinones; Seeds; Uracil; Uridine | 1981 |
Variation of favism-inducing factors (vicine, convicine and L-DOPA) during pod development in Vicia faba L.
Topics: Chromatography, High Pressure Liquid; Fabaceae; Favism; Glucosides; Levodopa; Plants, Medicinal; Pyrimidinones; Seeds; Toxins, Biological; Uridine | 1995 |
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.
Topics: Animals; Corpus Striatum; Cyclic GMP; Dyskinesia, Drug-Induced; Levodopa; Long-Term Synaptic Depression; Male; Microinjections; Neurons; Oxidopamine; Parkinsonian Disorders; Phosphodiesterase Inhibitors; Piperazines; Purinones; Pyrimidinones; Rats; Rats, Wistar | 2011 |